From January 1, 2024 to March 31, 2024, the company has repurchased 4,000,000 shares, representing 2.22% for CNY 35.97 million. With this, the company has completed the repurchase of 4,000,000 shares, representing 2.22% for CNY 35.97 million under the buyback announced on October 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.27 CNY | -0.32% | +1.42% | -21.90% |
Apr. 26 | Tibet AIM Pharm. Inc. Proposes Final Cash Dividend for 2023 | CI |
Apr. 25 | Tibet AIM Pharm. Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-21.90% | 240M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- 002826 Stock
- News Tibet AIM Pharm. Inc.
- Tranche Update on Tibet AIM Pharm. Inc.'s Equity Buyback Plan announced on October 30, 2023.